SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA ARTICLE M impact

Teva issues about $4.9B in notes; shifts ADS to NYSE

Teva Pharmaceutical Industries is refinancing debt with roughly $4.9B/€1.5B in notes and converting its ADS into ordinary shares for NYSE trading.

TEVA

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is reshaping its capital structure and market profile, issuing about $4.9B/€1.5B in notes to refinance debt while shifting ADS to ordinary shares for NYSE trading. The company also cited strong commercial momentum from AUSTEDO, AJOVY and UZEDY, biosimilar expansion and positiv…

Related stories